Dear Sen-Jam Community,

As our Wefunder campaign nears its close tomorrow night, we want to say a heartfelt thank you.

Your support has helped us achieve incredible progress across two lead therapeutics as well as our entire platform:

Now, we’re gearing up to close the campaign strong — so we can fully fund the Phase 2 trial for SJP-001 and maximize value for all stakeholders.

We’re also thrilled to share that Destum Partners has officially begun their global Strategic Partner outreach to unlock commercial and licensing opportunities. Their proven process is designed to convert our highly de-risked therapeutic assets into real-world market value —and we want every investor to be in position when that value is realized.

Final Countdown Incentives - Through Midnight Tomorrow Only

As we approach the finish line of this transformational raise, we're offering exclusive incentives to reward our investor community. There's only $600K worth of Fractional Royalty Right perks remaining from the “Sprint to $3M” campaign. These means an annual dividend for FRR holders for the life of the SJP-001 patent portfolio once a licensing deal is secured, targeting later this year.

We want to share these perks with you in our Final Countdown Incentive Package:

✅ $100,000+ — All $50K perks + 14% Bonus Shares + VIP Invite to our Licensing Deal Celebration at KVK Tech HQ

✅ $50,000+ — All $25K perks + 12% Bonus Shares + Dinner with Founders (in-person or virtual)

✅ $25,000+ — All $10K perks + 10% Bonus Shares + Monthly Call with CEO Jim for 6 Months + Cap Table Placement

✅ $10,000+ — All $5K perks + 20% FRR Kicker

✅ $5,000+ — All $1K perks + Tranche 3 Fractional Royalty Right (FRR) Terms

✅ $1,000+ — Sen-Jam "Good Karma Pharma People" Hat

Let’s Finish Strong!

💥 With 24 hours left this is your moment to invest in a company that’s ahead of the curve—and built for impact.

👉 Invest now on Wefunder

👉 Want to chat? Book a time with me HERE

Thank you for being part of this extraordinary journey. We’re building something that matters — and you’re at the heart of it.

Let’s do this…

Jim